arrow
S

Silvia Sookoian

Universidad Maimonides
H指数:62
被引数:2.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Author Correction: Towards a reference cell atlas of liver diversity over the human lifespan

作者更正:构建人类生命周期中肝脏多样性的参考细胞图谱

2025-10-230
OAAI
Towards a reference cell atlas of liver diversity over the human lifespan

构建覆盖人类生命历程的肝脏多样性参考细胞图谱

2025-10-130
PRE
Global, Regional, and National Burden of Primary Liver Cancer Attributable to Metabolic Risks: An Analysis of the Global Burden of Disease Study 1990-2021

可归因于代谢风险的原发性肝癌的全球,区域和国家负担: 对1990-2021全球疾病负担研究的分析

2025-10-017
PRE
Global Burden of Major Chronic Liver Diseases in 2021

全球主要慢性肝病负担2021年

2025-04-010
PRE
The role of dietary modification in the prevention and management of metabolic dysfunction-associated fatty liver disease: An international multidisciplinary expert consensus

饮食调整在预防和管理代谢功能障碍相关脂肪肝疾病中的作用: 国际多学科专家共识

2024-12-014
PRE
Global burden of disease attributable to metabolic risk factors in adolescents and young adults aged 15-39, 1990-2021

可归因于15-39岁青少年和年轻人代谢危险因素的全球疾病负担,1990-2021

2024-12-010
PRE
Burden of disease attributable to high body mass index: an analysis of data from the Global Burden of Disease Study 2021 (vol 76, 102848, 2024)
2024-12-010
PRE
Global burden of metabolic diseases, 1990-2021021

全球代谢性疾病负担,1990-2021021

2024-11-0110
PRE
Burden of disease attributable to high body mass index: an analysis of data from the Global Burden of Disease Study 2021

高体重指数导致的疾病负担: 全球疾病负担研究2021的数据分析

2024-10-011
OAAI
A global survey on the use of the international classification of diseases codes for metabolic dysfunction-associated fatty liver disease

关于使用国际疾病分类代码治疗代谢功能障碍相关脂肪肝疾病的全球调查

2024-06-159
PRE